References
- Viale P, Pagani L, Cristini F et al. Linezolid for the treatment of central nervous system infection in neurosurgical patients. Scand J Infect Dis 2000; 34; 456–459.
- Krueger W, Kottler B, Will B, et al. Treatment of meningitis due to methicillin-resistant Staphylococcus epider-midis with linezolid. J Clin Microbiol 2004; 42: 929–932.
- Hachem R, Afif C, Gokaslan Z, et al. Successful treat-ment of vancomycin-resistant enterococcus meningitis with linezolid. Eur J Clin Microbiol Inf Dis 2001; 20: 432–434.
- Shaikh Z, Peloquin C, Ericsson C. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 2001; 33: 375–379.
- Villani P, Regazzi M, Marubbi F, et al. Cerebrospinal fluid linezolid concentration in postneurosurgical central ner-vous system infection. Antimicrob Agents Chemother 2002; 46: 936–937.
- Amod F, Moodley I, Peer A, et al. Ventriculitis due to a heterostrain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combi-nation with intraventricular vancomycin. J Infect 2005; 50: 252–257.
- Zeana C, Kubin C, Della-Latta P, et al. Vancomycin-resistant Enterococcus faecium meningitis succeccfully man-aged with linezolid: case report and review of the literature. Clin Infect Dis 2001; 33: 477–482.
- Gill C, Murphy M, Hamer D. Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infec- tion with linezolid. J Infect 2002; 45: 129–132.
- Pistella E, Campanile F, Bongiorno D, et al. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand J Infect Dis 2004; 36: 222–237.
- Rupprecht T, Pfister H. Clinical experience with linezol-id for the treatment of central nervous system infections. Eur J Neurol 2005; 12: 536–542.
- Buerger C, Joukhadar C, Muller M, Kloft C. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B 2003; 796: 155–164.
- Jaqueline C, Caillon J, Le Mabecque V, et al. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J Antimicrob Chemother 2003; 51: 857–864.
- Dailey C, Pagano P, Buchanan L, et al. Efficacy of line-zolid plus rifampin in a experimental model of methicillin-sus-ceptible Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2003; 47: 2655–2658.
- Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition an pharmacokinetic variabil-ity. Clin Pharmacokinet 2005; 44: 1009–1034.
- Ruiz M, Guerrero I, Tuazon C. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin Infect Dis. 2002; 35: 1018–1020.